Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENTPD4 divergent transcript (ENTPD4-DT) is a long noncoding RNA gene located near the ENTPD4 gene on human chromosome 8[1][3][4]. It does not encode a protein, receptor, or enzyme, and there is currently no established biological function or disease association for this transcript. It serves as a genomic annotation for RNA transcription in the region, but not as a classical therapeutic target or drug-interacting molecule[1][2][3][4].\n\nIn summary: ENTPD4-DT is a lncRNA gene and not a molecular target or receptor. Selecting ENTPD4-DT as a receptor or therapeutic target would be incorrect according to current genomic annotations[2][3][4].
No known mechanisms since it is not a therapeutic target[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ENTPD4 divergent transcript (ENTPD4-DT).